Oxynov was founded at the Institut universitaire de cardiologie et de pneumologie de Québec with the support of all respirologists on staff.
Oxynov was founded in 2009 by two physician-researchers, François Lellouche (M.D., Ph.D.) and Erwan L’Her (M.D., Ph.D.), working in the field of respiratory health and conscious of the unmet needs of clinicians. OxyNov is a company focused on clinical innovation and on the marketing of its oxygen therapy devices.
Revolutionize oxygen therapy and respiratory assistance through an approach that combines medical research with technological innovation to develop a range of interrelated solutions to:
At the beginning of 2017, OxyNov will target the European hospital market with FreeO2, a unique solution that revolutionizes oxygen therapy, the treatment most frequently administered in hospitals.
OxyNov boasts a team of experienced individuals with complementary skill sets. With various cultural backgrounds and impressive international career paths, the team members bring to the company the capacity for innovation and the potential for global development.